Adding Glucose-Lowering Agents Delays Insulin Initiation and Prolongs Hyperglycemia

摘要

Objectives: Nine classes of glucose-lowering agents (GLAs) are available for patients with type 2 diabetes prior to starting insulin. This study's aim was to determine if the number of GLAs is associated with a difference in glycated hemoglobin (A1C) at insulin initiation in the US Department of Veterans Affairs Health Care System (VAHCS).